Mammography Market – Overview

In 2022, the mammography market was valued at USD 2.5 billion. The mammography industry is expected to expand from USD 2.73 billion in 2023 to USD 5.54 billion by 2032, with a compound annual growth rate (CAGR) of 9.25% over the forecast period (2023-2032).

The diagnostic mammogram market offers vital insights into breast health, aiding in early detection of abnormalities. With advancements in technology, such as digital mammography, the market continues to grow. Screening programs and awareness initiatives further drive demand. This market plays a crucial role in women's healthcare, promoting early intervention and improved outcomes.

The mammography market is anticipated to expand due to factors such as an increase in the number of breast cancer cases, more female awareness, technological innovations, and an increase in the number of government programs. Rising healthcare costs, a burgeoning healthcare industry, and a growing desire for more frequent monitoring are just a few of the primary factors expected to drive mammography machine demand in the coming years.

Competitive Analysis

The contemporary landscape drives end-to-end transformation, from the rapid adoption of new working practices to the incubation of new business models. Players will benefit from seeking out new collaborations and curating value ecosystems to move faster while developing new products and services that meet customer expectations. Customer expectations and experiences are being transformed by technology, and it's occurring quicker than ever before. Leaders play a critical role in implementing modern technology and data to combine processes that meet evolving needs as digital acceleration transforms industries and customer and employee expectations. The COVID-19 outbreak is still changing the world as we know it, particularly in terms of how we behave and interact as organizations and as individuals. Some industries are expected to rebound faster than others, reflecting shifts in consumer behavior. The pandemic has sparked change, typically in the area of digital transformation, and a variety of projects ranging from virtual sales and service to e-commerce to data acceleration are not only swiftly becoming a new directive but are also becoming a new standard.

The mammography key players are Siemens Healthcare GmbH (Germany), Shimadzu Corporation (Japan), FUJIFILM Holdings Corporation (Japan), General Electric Company (U.S.), Koninklijke Philips (Netherland), Carestream Health, Inc. (U.S.), Hitachi Medical Corporation (Japan), Toshiba Medical Systems Corporation (Japan), and Hologic, Inc (U.S.).

Segment Analysis

The segmentation of the mammography market is conducted based on type, treatment, end user, and region. The type segment of the mammography market consists of diagnostic mammograms and screening mammograms. The region segment of the mammography market consists of Europe, Asia-Pacific, Americas, and Middle East & Africa. The treatment segment of the mammography market consists of digital systems, film-screen systems, breast tomosynthesis, and analog systems. The end-user segment of the mammography market consists of hospitals, diagnostic centers, research institutes, and specialty clinics.

Regional Analysis

The regional assessment of the mammography market includes regions such as the Americas, Europe, Asia-Pacific, and the Middle East, and Africa. The mammography market in the Americas is expected to dominate the global industry due to the rising incidence of breast cancer and rising per capita healthcare spending in the region. The European market is rapidly developing. This is attributable to the presence of a well-established healthcare system and increased government incentives to develop innovative treatment options, and the mammography market share is predicted to grow rapidly. Breast cancer surgeries and medicines, for example, have become more efficient since the advent of next-generation 3D mammography technology.